Risk evaluation - risk less by asking earlier

The RACT plus facilitates the identification as well as the qualitative assessment of clinical trial risks. The result is a list of prioritized risks that informs which of them require closer monitoring.

RACT plus enhances the original RACT (Risk Assessment and Categorization Tool) of TransCelerate with until now unavailable risk level definitions.

Every RACT question is improved with objective descriptions of high, medium and low risk levels for each of the following risk attributes:



  • Risk impact
  • Risk likelihood
  • Risk detectability

With RACT plus, the customer benefits from:

  • Timely risk identification
  • Objective assessment of risks and
  • Tailored risk-response planning

The resulting Risk Management Plan will additionally set up the basis for time- and cost-efficient risk-based monitoring (RBM).